Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between bipolar disorder and rare loss-of-function variants in two genes.

Scientists at deCODE genetics/Amgen have identified associations between bipolar disorder and rare loss-of-function variants ...

Schizophrenia affects millions worldwide, yet its causes remain one of the greatest medical mysteries. In an exclusive ...

Bipolar disorder is a severe mental illness characterized by ... platforms to help find new drugs quicker and to personalize ...

Researchers cite similarities in symptoms, genetic links, and similar patterns in brain changes as reasons for this connection. With bipolar disorder, you might also experience symptoms of ...

A new study highlights the placenta’s role in neuropsychiatric development, showing that DNA methylation influences gene ...

The purpose of this study is to create a database of information that allows researchers to explore how genetics and other biomarkers are impacted by bipolar disorder and its treatment.

An international team has identified associations between modifications in the placenta and the risk of developing schizophrenia, bipolar disorder, and major depression disorder.

Kari Stefansson CEO of deCODE genetics  withThorgeir Thorgeirsson and Vinicius Tragante, scientists at deCODE genetics and ...

Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between rare ...

Kari Stefansson and Thorgeir Thorgeirsson discuss the paper -Rare loss-of-function variants in HECTD2 and AKAP11 confer risk of bipolar disorder - published in Nature Genetics.